Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Yen set for weekly loss but vaccine boost wanes

Published 2020-11-12, 07:30 p/m
© Reuters. FILE PHOTO: Illustration photo of a Japan Yen note

By Tom Westbrook

SYDNEY (Reuters) - The dollar headed for its best week against the yen since March on Friday, as COVID-19 vaccine news lured investors out of the Japanese safe haven, though riskier currencies have made little headway as the pandemic worsens in Europe and the United States.

Virus worries helped the yen recoup a little of its losses overnight, lifting it 0.3% against the greenback, but it remains about 1.7% lower for the week, which if sustained would be its sharpest weekly drop since falling 2.4% in the panic of March.

It was steady at 105.05 yen per dollar

"There are reasons to be optimistic about the global economic recovery, and eventual pandemic submission over the coming year, but we are not out woods yet," said National Australia bank's senior currency strategist Rodrigo Catril.

"The Aussie continues to find the air thinning above 73 cents."

The Aussie

The euro (EUR=) rose marginally overnight to clamber back over $1.18, but it is down about 0.6% for the week so far. The dollar index (=USD) is up 0.7% this week. The Chinese yuan

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In Europe and the United States, a second wave of infections has prompted the re-imposition of restrictions to stop the virus' spread. That will have markets discounting any good news in eurozone growth numbers due later on Friday.

"The GDP report will have minimal impact on the euro with analysts, including ourselves, now widely expecting a double‑dip recession in the euro zone starting in the fourth quarter," said Commonwealth Bank of Australia analyst Kim Mundy in a note.

Central bank chiefs likewise warned that the crisis has some way to run, even with the end now in sight thanks to Pfizer (NYSE:PFE)'s announcement this week that trials have showed the vaccine it developed with Germany's BioNTech seems to work.

"From a huge river of uncertainty, we see the other side now," said European Central Bank President Christine Lagarde in a panel discussion with U.S. Federal Reserve Chair Jerome Powell and Bank of England Governor Andrew Bailey.

"But I don't want to be exuberant about this vaccination because there is still uncertainty," she said, about its production and distribution.

========================================================

Currency bid prices at 11:25AM in Sydney (0025 GMT)

Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid

Previous Change

Session

Euro/Dollar (EUR=EBS) $1.1810 $1.1804 +0.05% +5.34% +1.1810 +1.1803

Dollar/Yen

Euro/Yen (EURJPY=) 124.03 124.11 -0.06% +1.71% +124.1400 +124.0300

Dollar/Swiss

Sterling/Dollar

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Dollar/Canadian

Aussie/Dollar

NZ

Dollar/Dollar

All spots

Tokyo spots

Europe spots

Volatilities

Tokyo Forex market info from BOJ

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.